Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

Recruiting now

Conditions studied: Prostate Cancer (Diagnosis), Prostate Cancer Patients Who Have Brachytherapy Seed Implant, Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer Recurrent

In brief

Analysis of peripheral immune cells before, during, and after brachytherapy treatment. Corresponding analysis of tissue samples collected during brachytherapy treatment.

Key facts

Study ID

NCT07131956

Run by

University of Erlangen-Nürnberg Medical School

People needed

200

Starts

2025-12-01

Expected to finish

2028-07-31

Last updated by the study team

2025-11-18

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may not qualify if…

• Pre-existent auto-immune disease
• patients under bloodthinning medication
• substance abuse

Where it is running

• Strahlenklinik Erlangen — Erlangen, Bavaria, Germany (enrolling)
• Klinik für Strahlentherapie — Augsburg, Bavaria, Germany
• Klinik und Poliklinik für Strahlentherapie und Radioonkologie — Munich, Bavaria, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.